Evidence of CNIH3 involvement in opioid dependence

Molecular Psychiatry

Volumn 21, Issue 5, 2016, Pages 608-614

  Nelson, E C ^a,r   Agrawal, A ^a   Heath, A C ^a   Bogdan, R ^a   Sherva, R ^b   Zhang, B ^a   Al Hasani, R ^a   Bruchas, M R ^a   Chou, Y L ^a   Demers, C H ^a   Carey, C E ^a   Conley, E D ^c   Fakira, A K ^d   Farrer, L A ^b   Goate, A ^e   Gordon, S ^f   Henders, A K ^f   Hesselbrock, V ^g   Kapoor, M ^e   Lynskey, M T ^h   Madden, P A F ^a   Moron, J A ^d   Rice, J P ^a   Saccone, N L ^a   Schwab, S G ⁱ   Shand, F L ^j   Todorov, A A ^a   Wallace, L ^f   Wang, T ^a   Wray, N R ^k   Zhou, X ^l   Degenhardt, L ^m   Martin, N G ^f   Hariri, A R ⁿ   Kranzler, H R ^o   Gelernter, J ^p   Bierut, L J ^a   Clark, D J ^q   Montgomery, G W ^f   more..

^a WASHINGTON UNIVERSITY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c College of Physicians and Surg ^*  (United States)

^d Icahn School of Medicine at Mount Sinai ^*  (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^f QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^g UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^h KING'S COLLEGE LONDON   (United Kingdom)

ⁱ UNIVERSITY OF WOLLONGONG   (Australia)

^j BLACK DOG INSTITUTE   (Australia)

^k UNIVERSITY OF QUEENSLAND   (Australia)

^l ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^m UNIVERSITY OF NEW SOUTH WALES   (Australia)

ⁿ DUKE UNIVERSITY   (United States)

^o UNIVERSITY OF PENNSYLVANIA   (United States)

^p YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^q STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^r WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; CHLORPHENIRAMINE MALEATE PLUS PHENYLEPHRINE; CNIH3 PROTEIN; GLUTAMATE RECEPTOR INTERACTING PROTEIN 1; GLUTAMATE RECEPTOR IONOTROPIC AMPA 1; GLUTAMATE RECEPTOR IONOTROPIC AMPA 2; MORPHINE; PROTEIN; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT GAMMA SUBUNIT 8; CNIH2 PROTEIN, MOUSE; CNIH3 PROTEIN, HUMAN; CNIH3 PROTEIN, MOUSE;

ADULT; ALCOHOLISM; AMYGDALA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG DEPENDENCE; EPIGENETICS; FACIAL EXPRESSION; FEMALE; FETAL BRAIN; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HABITUATION; HAPLOTYPE; HUMAN; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MOUSE; NEUROIMAGING; NONHUMAN; OPIATE ADDICTION; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; DIAGNOSTIC IMAGING; GENETIC PREDISPOSITION; GENETICS; INBRED MOUSE STRAIN; META ANALYSIS; METABOLISM; PHYSIOLOGY; SPECIES DIFFERENCE; YOUNG ADULT;

AMYGDALA; ANIMALS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HABITUATION, PSYCHOPHYSIOLOGIC; HUMANS; MALE; MICE, INBRED STRAINS; OPIOID-RELATED DISORDERS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, AMPA; SPECIES SPECIFICITY; YOUNG ADULT;

EID: 84938635051     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2015.102     Document Type: Article

References (62)

1. Merikangas KR, Stolar M, Stevens DE, Goulet J, Preisig MA, Fenton B et al. Familial transmission of substance use disorders. Arch Gen Psychiatry 1998; 55: 973-979
2. Tsuang MT, Lyons MJ, Meyer JM, Doyle T, Eisen SA, Goldberg J et al. Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities. Arch Gen Psychiatry 1998; 55: 967-972
3. Kendler KS, Jacobson KC, Prescott CA, Neale MC. Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins. Am J Psychiatry 2003; 160: 687-695
4. Sun J, Bi J, Chan G, Oslin D, Farrer L, Gelernter J et al. Improved methods to identify stable, highly heritable subtypes of opioid use and related behaviors. Addict Behav 2012; 37: 1138-1144
5. Agrawal A, Verweij KJ, Gillespie NA, Heath AC, Lessov-Schlaggar CN, Martin NG et al. The genetics of addiction-A translational perspective. Transl Psychiatry 2012; 2: e140
6. Nelson EC, Lynskey MT, Heath AC, Wray N, Agrawal A, Shand FL et al. Association of OPRD1 polymorphisms with heroin dependence in a large case-control series. Addict Biol 2014; 19: 111-121
7. Nelson EC, Lynskey MT, Heath AC, Wray N, Agrawal A, Shand F et al. ANKK1, TTC12, and NCAM1 polymorphisms and heroin dependence: importance of considering drug exposure. JAMA Psychiatry 2013; 70: 325-333
8. Peng S, Du J, Jiang H, Fu Y, Chen H, Sun H et al. The dopamine receptor D1 gene is associated with the length of interval between first heroin use and onset of dependence in Chinese Han heroin addicts. J Neural Transm 2013; 120: 1591-1598
9. Wellcome Trust Case Control Consortium. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature 2007; 447: 661-678
10. Nutt D, King LA, Saulsbury W, Blakemore C. Development of a rational scale to assess the harm of drugs of potential misuse. Lancet 2007; 369: 1047-1053
11. Linares OA. The Linares addictive potential model. J Pharm Nutr Sci 2012; 2: 132-139
12. Anthony JC, Warner LA, Kessler RC. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants basic findings From the National Comorbidity Survey. Exp Clin Psychopharmacol 1994; 2: 244-268
13. Saccone SF, Hinrichs AL, Saccone NL, Chase GA, Konvicka K, Madden PAF et al. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet 2007; 16: 36-49
14. Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, Magnusson KP et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 2008; 452: 638-642
15. Liu JZ, Tozzi F, Waterworth DM, Pillai SG, Muglia P, Middleton L et al. Meta-Analysis and imputation refines the association of 15q25 with smoking quantity. Nat Genet 2010; 42: 436-440
16. Thorgeirsson TE, Gudbjartsson DF, Surakka I, Vink JM, Amin N, Geller F et al. Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat Genet 2010; 42: 448-453
17. Tobacco and Genetics Consortium. Genome-wide meta-Analyses identify multiple loci associated with smoking behavior. Nat Genet 2010; 42: 441-447
18. Bierut LJ, Goate AM, Breslau N, Johnson EO, Bertelsen S, Fox L et al. ADH1B is associated with alcohol dependence and alcohol consumption in populations of European and African ancestry. Mol Psychiatry 2012; 17: 445-450
19. Gelernter J, Kranzler HR, Sherva R, Almasy L, Koesterer R, Smith AH et al. Genomewide association study of alcohol dependence: significant findings in African- and European-Americans including novel risk loci. Mol Psychiatry 2014; 19: 41-49
20. Shand FL, Degenhardt L, Slade T, Nelson EC. Sex differences amongst dependent heroin users: histories, clinical characteristics and predictors of other substance dependence. Addict Behav 2011; 36: 27-36
21. Bierut LJ, Agrawal A, Bucholz KK, Doheny KF, Laurie C, Pugh E et al. A genomewide association study of alcohol dependence. Proc Natl Acad Sci USA 2010; 107: 5082-5087
22. Bennett SN, Caporaso N, Fitzpatrick AL, Agrawal A, Barnes K, Boyd HA et al. Phenotype harmonization and cross-study collaboration in GWAS consortia: the GENEVA experience. Genet Epidemiol 2011; 35: 159-173
23. Gelernter J, Kranzler HR, Sherva R, Koesterer R, Almasy L, Zhao H et al. Genomewide association study of opioid cependence: multiple associations mapped to calcium and potassium pathways. Biol Psychiatry 2014; 76: 66-74
24. Gelernter J, Sherva R, Koesterer R, Almasy L, Zhao H, Kranzler HR et al. Genomewide association study of cocaine dependence and related traits: FAM53B identified as a risk gene. Mol Psychiatry 2014; 19: 717-723
25. Okvist A, Fagergren P, Whittard J, Garcia-Osta A, Drakenberg K, Horvath MC et al. Dysregulated postsynaptic density and endocytic zone in the amygdala of human heroin and cocaine abusers. Biol Psychiatry 2011; 69: 245-252
26. Cai YQ, Wang W, Hou YY, Zhang Z, Xie J, Pan ZZ. Central amygdala GluA1 facilitates associative learning of opioid reward. J Neurosci 2013; 33: 1577-1588
27. Van Den Oever MC, Goriounova NA, Li KW, Van Der Schors RC, Binnekade R, Schoffelmeer AN et al. Prefrontal cortex AMPA receptor plasticity is crucial for cue-induced relapse to heroin-seeking. Nat Neurosci 2008; 11: 1053-1058
28. Xia Y, Portugal GS, Fakira AK, Melyan Z, Neve R, Lee HT et al. Hippocampal GluA1- containing AMPA receptors mediate context-dependent sensitization to morphine. J Neurosci 2011; 31: 16279-16291
29. Aitta-Aho T, Möykkynen TP, Panhelainen AE, Vekovischeva OY, Bäckström P, Korpi ER. Importance of GluA1 subunit-containing AMPA glutamate receptors for morphine state-dependency. PLoS One 2012; 7: e38325
30. Bucholz KK, Cadoret R, Cloninger CR, Dinwiddie SH, Hesselbrock VM, Nurnberger JI Jr. et al. A new, semi-structured psychiatric interview for use in genetic linkage studies: a report on the reliability of the SSAGA. J Stud Alcohol 1994; 55: 149-158
31. Patterson N, Price AL, Reich D. Population structure and eigenanalysis. PLoS Genet 2006; 2: e190
32. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575
33. Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-Analysis of genomewide association scans. Bioinformatics 2010; 26: 2190-2191
34. So HC, Gui AH, Cherny SS, Sham PC. Evaluating the heritability explained by known susceptibility variants: a survey of ten complex diseases. Genet Epidemiol 2011; 35: 310-317
35. Hall WD, Ross JE, Lynskey MT, Law MG, Degenhardt LJ. How many dependent heroin users are there in Australia?. Med J Aust 2000; 173: 528-531
36. Degenhardt L, Hall W. The extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet 2012; 379: 55-70
37. Whalen PJ, Phelps EA (eds). The Human Amygdala. Guilford Press: New York, NY, USA, 2009
38. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Stat Methodol 1995; 57: 289-300
39. Sun H, Maze I, Dietz DM, Scobie KN, Kennedy PJ, Damez-Werno D et al. Morphine epigenomically regulates behavior through alterations in histone H3 lysine 9 dimethylation in the nucleus accumbens. J Neurosci 2012; 32: 17454-17464
40. Zhou X, Maricque B, Xie M, Li D, Sundaram V, Martin EA et al. The Human Epigenome Browser at Washington University. Nat Methods 2011; 8: 989-990
41. Zhou X, Lowdon RF, Li D, Lawson HA, Madden PAF, Costello JF et al. Exploring long-range genome interactions using the WashU Epigenome Browser. Nat Methods 2013; 10: 375-376
42. Zhou X, Li D, Zhang B, Lowdon RF, Rockweiler NB, Sears RL et al. Epigenomic annotation of genetic variants using the Roadmap Epigenome Browser. Nat Biotechnol 2015; 33: 345-346
43. Yeh SH, Mao SC, Lin HC, Gean PW. Synaptic expression of glutamate receptor after encoding of fear memory in the rat amygdala. Mol Pharmacol 2006; 69: 299-308
44. Dalton GL, Wang YT, Floresco SB, Phillips AG. Disruption of AMPA receptor endocytosis impairs the extinction, but not acquisition of learned fear. Neuropsychopharmacology 2008; 33: 2416-2426
45. Nedelescu H, Kelso CM, Lázaro-Muñoz G, Purpura M, Cain CK, Ledoux JE et al. Endogenous GluR1-containing AMPA receptors translocate to asymmetric synapses in the lateral amygdala during the early phase of fear memory formation: an electron microscopic immunocytochemical study. J Comp Neurol 2010; 518: 4723-4739
46. Nikolova YS, Koenen KC, Galea S, Wang CM, Seney ML, Sibille E et al. Beyond genotype: serotonin transporter epigenetic modification predicts human brain function. Nat Neurosci 2014; 17: 1153-1155
47. Plichta MM, Grimm O, Morgen K, Mier D, Sauer C, Haddad L et al. Amygdala habituation: a reliable fMRI phenotype. Neuroimage 2014; 103C: 383-390
48. Chu LF, Liang DY, Li X, Sahbaie P, D'arcy N, Liao G et al. From mouse to man: the 5-HT3 receptor modulates physical dependence on opioid narcotics. Pharmacogenet Genomics 2009; 19: 193-205
49. Zheng M, Dill D, Peltz G. A better prognosis for genetic association studies in mice. Trends Genet 2012; 28: 62-69
50. Liang DY, Zheng M, Sun Y, Sahbaie P, Low SA, Peltz G et al. The Netrin-1 receptor DCC is a regulator of maladaptive responses to chronic morphine administration. BMC Genomics 2014; 15: 345
51. Schwenk J, Baehrens D, Haupt A, Bildl W, Boudkkazi S, Roeper J et al. Regional diversity and developmental dynamics of the AMPA-receptor proteome in the mammalian brain. Neuron 2014; 84: 41-54
52. Sumioka A, Brown TE, Kato AS, Bredt DS, Kauer JA, Tomita S. PDZ binding of TARP?-8 controls synaptic transmission but not synaptic plasticity. Nat Neurosci 2011; 14: 1410-1412
53. Harmel N, Cokic B, Zolles G, Berkefeld H, Mauric V, Fakler B et al. AMPA receptors commandeer an ancient cargo exporter for use as an auxiliary subunit for signaling. PLoS One 2012; 7: e30681
54. Herring BE, Shi Y, Suh YH, Zheng CY, Blankenship SM, Roche KW et al. Cornichon proteins determine the subunit composition of synaptic AMPA receptors. Neuron 2013; 77: 1083-1096
55. Coombs ID, Soto D, Zonouzi M, Renzi M, Shelley C, Farrant M et al. Cornichons modify channel properties of recombinant and glial AMPA receptors. J Neurosci 2012; 32: 9796-9804
56. Boudkkazi S, Brechet A, Schwenk J, Fakler B. Cornichon2 dictates the time course of excitatory transmission at individual hippocampal synapses. Neuron 2014; 82: 848-858
57. Shanks NF, Cais O, Maruo T, Savas JN, Zaika EI, Azumaya CM et al. Molecular dissection of the interaction between the AMPA receptor and cornichon homolog-3. J Neurosci 2014; 34: 12104-12120
58. Lonsdale J, Thomas J, Salvatore M, Phillips R, Lo E et al. GTEx Consortium, The genotype-Tissue expression (GTEx) project. Nat Genet 2013; 45: 580-585
59. Duffy DL, Iles MM, Glass D, Zhu G, Barrett JH, Höiom V et al. IRF4 variants have age-specific effects on nevus count and predispose to melanoma. Am J Hum Genet 2010; 87: 6-16
60. Gunduz-Cinar O, MacPherson KP, Cinar R, Gamble-George J, Sugden K, Williams B et al. Convergent translational evidence of a role for anandamide in amygdalamediated fear extinction, threat processing and stress-reactivity. Mol Psychiatry 2013; 18: 813-823
61. Day CA, Ross J, Dietze P, Dolan K. Initiation to heroin injecting among heroin users in Sydney, Australia: cross sectional survey. Harm Reduct J 2005; 2: 2
62. Des Jarlais DC, Arasteh K, Perlis T, Hagan H, Heckathorn DD, Mcknight C et al. The transition from injection to non-injection drug use: long-Term outcomes among heroin and cocaine users in New York City. Addiction 2007; 102: 778-785